Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Tumour-infiltrating lymphocytes: from prognosis to treatment selection
K Brummel, AL Eerkens, M de Bruyn… - British Journal of …, 2023 - nature.com
Tumour-infiltrating lymphocytes (TILs) are considered crucial in anti-tumour immunity.
Accordingly, the presence of TILs contains prognostic and predictive value. In 2011, we …
Accordingly, the presence of TILs contains prognostic and predictive value. In 2011, we …
Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer
H Zhou, L Zhu, J Song, G Wang, P Li, W Li, P Luo… - Molecular cancer, 2022 - Springer
Colorectal cancer (CRC) is one of the most common cancers worldwide and a leading
cause of carcinogenic death. To date, surgical resection is regarded as the gold standard by …
cause of carcinogenic death. To date, surgical resection is regarded as the gold standard by …
Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology
KE Stanley, T Jatsenko, S Tuveri, D Sudhakaran… - Nature …, 2024 - nature.com
Circulating cell-free DNA (cfDNA) fragments have characteristics that are specific to the cell
types that release them. Current methods for cfDNA deconvolution typically use disease …
types that release them. Current methods for cfDNA deconvolution typically use disease …
[HTML][HTML] FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
T Regulatory cells (Tregs) can have both protective and pathological roles. They maintain
immune homeostasis and inhibit immune responses in various diseases, including cancer …
immune homeostasis and inhibit immune responses in various diseases, including cancer …
PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies
KX Lin, AC Istl, D Quan, A Skaro, E Tang… - Cancer immunology …, 2023 - Springer
Colorectal cancer (CRC) is the second most common cause of cancer mortality, with
mismatch repair proficient (pMMR) and/or microsatellite stable (MSS) CRC making up more …
mismatch repair proficient (pMMR) and/or microsatellite stable (MSS) CRC making up more …
Reactive oxygen species bridge the gap between chronic inflammation and tumor development
W Yu, Y Tu, Z Long, J Liu, D Kong… - Oxidative medicine …, 2022 - Wiley Online Library
According to numerous animal studies, adverse environmental stimuli, including physical,
chemical, and biological factors, can cause low‐grade chronic inflammation and subsequent …
chemical, and biological factors, can cause low‐grade chronic inflammation and subsequent …
Regulatory T cell and macrophage crosstalk in acute lung injury: future perspectives
T Guan, X Zhou, W Zhou, H Lin - Cell Death Discovery, 2023 - nature.com
Acute lung injury (ALI) describes the injury to endothelial cells in the lungs and associated
vessels due to various factors. Furthermore, ALI accompanied by inflammation and …
vessels due to various factors. Furthermore, ALI accompanied by inflammation and …
PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer
X Wang, R Sun, S Chan, L Meng, Y Xu, X Zuo… - Frontiers in …, 2022 - frontiersin.org
PANoptosis is a newly-discovered cell death pathway that involves crosstalk and co-
ordination between pyroptosis, apoptosis, and necroptosis processes. However, the roles of …
ordination between pyroptosis, apoptosis, and necroptosis processes. However, the roles of …
Targeting Tim-3 in cancer with resistance to PD-1/PD-L1 blockade
T Tian, Z Li - Frontiers in oncology, 2021 - frontiersin.org
Programmed death receptor 1 (PD-1) or programmed death ligand 1 (PD-L1) blocking
therapy has completely changed the treatment pattern of malignant tumors. It has been …
therapy has completely changed the treatment pattern of malignant tumors. It has been …
Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer
Despite recent advances in colorectal cancer (CRC) treatment, a large proportion of patients
show limited responses to therapies, especially in advanced stages. There is an urgent …
show limited responses to therapies, especially in advanced stages. There is an urgent …